FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2793466037> ?p ?o ?g. }

• W2793466037 endingPage "504" @default.
• W2793466037 startingPage "496" @default.
• W2793466037 abstract "Recent clinical studies have suggested that denosumab is associated with tumor response and reduced surgical morbidity in patients with giant-cell tumor of bone (GCTB). We therefore evaluated the recurrence-free survival rate of patients who had GCTB in an extremity and were treated with surgery and denosumab, to determine the influence of denosumab and clinical factors on the risk of local recurrence.We retrospectively reviewed the medical records of 408 patients treated for GCTB in an extremity in a single institution from 1990 through 2013. Two hundred and forty-seven patients underwent curettage (intralesional surgery) with a high-speed burr, and 161 underwent resection. Phenol adjuvant was used in 221 of the 247 patients who had curettage. We also reviewed the medical records of 30 patients treated surgically (25 with curettage and 5 with resection) and with denosumab from 2010 through 2013 and compared their clinical results with 378 historical control subjects. The overall minimum duration of follow-up was 24 months.The local recurrence rates were 60% (15) of 25 patients treated with curettage and denosumab and 16% (36) of 222 patients treated with curettage alone. The joint preservation rates were 80% (20) of 25 patients treated with curettage and denosumab and 94% (209) of 222 patients treated with curettage alone. Univariate and multivariable analyses showed that denosumab was the only independent factor associated with a poor prognosis when recurrence-free survival and joint preservation were considered. The overall median duration of follow-up was 85.6 months (interquartile range, 54.3 to 125.1 months). Viable tumor was present in all 30 specimens from patients treated with denosumab.There was a higher rate of recurrence in the cohort exposed to denosumab. Because there were substantial differences in the cohorts and randomization was not applied, however, causation could not be evaluated.Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence." @default.
• W2793466037 created "2018-03-29" @default.
• W2793466037 creator A5011487326 @default.
• W2793466037 creator A5014709522 @default.
• W2793466037 creator A5026197189 @default.
• W2793466037 creator A5070383055 @default.
• W2793466037 creator A5077469626 @default.
• W2793466037 creator A5082187394 @default.
• W2793466037 creator A5086814670 @default.
• W2793466037 date "2018-03-21" @default.
• W2793466037 modified "2023-10-03" @default.
• W2793466037 title "Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage" @default.
• W2793466037 cites W1507649428 @default.
• W2793466037 cites W1965247641 @default.
• W2793466037 cites W1967756360 @default.
• W2793466037 cites W1987418771 @default.
• W2793466037 cites W2028541032 @default.
• W2793466037 cites W2076395246 @default.
• W2793466037 cites W2080074604 @default.
• W2793466037 cites W2081470886 @default.
• W2793466037 cites W2109036427 @default.
• W2793466037 cites W2123114700 @default.
• W2793466037 cites W2123384771 @default.
• W2793466037 cites W2123534406 @default.
• W2793466037 cites W2145043990 @default.
• W2793466037 cites W2145928668 @default.
• W2793466037 cites W2152071898 @default.
• W2793466037 cites W2169622773 @default.
• W2793466037 cites W2170188347 @default.
• W2793466037 cites W2186876643 @default.
• W2793466037 cites W2299351315 @default.
• W2793466037 cites W2326565909 @default.
• W2793466037 cites W2340908491 @default.
• W2793466037 cites W2414485509 @default.
• W2793466037 cites W2508842317 @default.
• W2793466037 cites W2548999407 @default.
• W2793466037 cites W2595600314 @default.
• W2793466037 cites W4292542148 @default.
• W2793466037 doi "https://doi.org/10.2106/jbjs.17.00057" @default.
• W2793466037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29557866" @default.
• W2793466037 hasPublicationYear "2018" @default.
• W2793466037 type Work @default.
• W2793466037 sameAs 2793466037 @default.
• W2793466037 citedByCount "119" @default.
• W2793466037 countsByYear W27934660372017 @default.
• W2793466037 countsByYear W27934660372018 @default.
• W2793466037 countsByYear W27934660372019 @default.
• W2793466037 countsByYear W27934660372020 @default.
• W2793466037 countsByYear W27934660372021 @default.
• W2793466037 countsByYear W27934660372022 @default.
• W2793466037 countsByYear W27934660372023 @default.
• W2793466037 crossrefType "journal-article" @default.
• W2793466037 hasAuthorship W2793466037A5011487326 @default.
• W2793466037 hasAuthorship W2793466037A5014709522 @default.
• W2793466037 hasAuthorship W2793466037A5026197189 @default.
• W2793466037 hasAuthorship W2793466037A5070383055 @default.
• W2793466037 hasAuthorship W2793466037A5077469626 @default.
• W2793466037 hasAuthorship W2793466037A5082187394 @default.
• W2793466037 hasAuthorship W2793466037A5086814670 @default.
• W2793466037 hasBestOaLocation W27934660372 @default.
• W2793466037 hasConcept C119060515 @default.
• W2793466037 hasConcept C126322002 @default.
• W2793466037 hasConcept C141071460 @default.
• W2793466037 hasConcept C142724271 @default.
• W2793466037 hasConcept C144301174 @default.
• W2793466037 hasConcept C2776286101 @default.
• W2793466037 hasConcept C2776541429 @default.
• W2793466037 hasConcept C2776886416 @default.
• W2793466037 hasConcept C2777190185 @default.
• W2793466037 hasConcept C2777308945 @default.
• W2793466037 hasConcept C2779904257 @default.
• W2793466037 hasConcept C38180746 @default.
• W2793466037 hasConcept C71924100 @default.
• W2793466037 hasConcept C77076574 @default.
• W2793466037 hasConceptScore W2793466037C119060515 @default.
• W2793466037 hasConceptScore W2793466037C126322002 @default.
• W2793466037 hasConceptScore W2793466037C141071460 @default.
• W2793466037 hasConceptScore W2793466037C142724271 @default.
• W2793466037 hasConceptScore W2793466037C144301174 @default.
• W2793466037 hasConceptScore W2793466037C2776286101 @default.
• W2793466037 hasConceptScore W2793466037C2776541429 @default.
• W2793466037 hasConceptScore W2793466037C2776886416 @default.
• W2793466037 hasConceptScore W2793466037C2777190185 @default.
• W2793466037 hasConceptScore W2793466037C2777308945 @default.
• W2793466037 hasConceptScore W2793466037C2779904257 @default.
• W2793466037 hasConceptScore W2793466037C38180746 @default.
• W2793466037 hasConceptScore W2793466037C71924100 @default.
• W2793466037 hasConceptScore W2793466037C77076574 @default.
• W2793466037 hasIssue "6" @default.
• W2793466037 hasLocation W27934660371 @default.
• W2793466037 hasLocation W27934660372 @default.
• W2793466037 hasLocation W27934660373 @default.
• W2793466037 hasOpenAccess W2793466037 @default.
• W2793466037 hasPrimaryLocation W27934660371 @default.
• W2793466037 hasRelatedWork W2793466037 @default.
• W2793466037 hasRelatedWork W2810836821 @default.
• W2793466037 hasRelatedWork W3017270174 @default.
• W2793466037 hasRelatedWork W3034190030 @default.

• next